Innate Pharma S.A. (IPHA)
NASDAQ: IPHA · IEX Real-Time Price · USD
2.640
+0.270 (11.39%)
Mar 28, 2024, 3:10 PM EDT - Market open

Innate Pharma Stock Forecast

Stock Price Forecast

The 1 analyst with a 12-month price forecast for Innate Pharma stock has a target of 11.5, which predicts an increase of 335.61% from the current stock price of 2.64.

Analyst Consensus: Strong Buy
Target Low Average Median High
Price $11.5 $11.5 $11.5 $11.5
Change +335.61% +335.61% +335.61% +335.61%

Analyst Ratings

According to 1 stock analyst, the rating for Innate Pharma is "Strong Buy". This means that the analyst believes this stock is likely to perform very well in the near future and significantly outperform the market.

Recommendation Trends

Rating Oct '23Nov '23Dec '23Jan '24Feb '24Mar '24
Strong Buy 111111
Buy 111110
Hold 000000
Sell 000000
Strong Sell 000000
Total 222221

Latest Forecasts

Analyst Firm Rating Rating Action Price Target Upside Date
HC Wainwright & Co.
HC Wainwright & Co.
Strong Buy
Reiterates
$12
Strong Buy Reiterates $12 +335.61% Mar 22, 2024
HC Wainwright & Co.
HC Wainwright & Co.
Strong Buy
Reiterates
$12
Strong Buy Reiterates $12 +335.61% Nov 15, 2023
HC Wainwright & Co.
HC Wainwright & Co.
Strong Buy
Reiterates
$12
Strong Buy Reiterates $12 +335.61% Sep 18, 2023
HC Wainwright & Co.
HC Wainwright & Co.
Strong Buy
Reiterates
$12
Strong Buy Reiterates $12 +335.61% Jun 16, 2023
HC Wainwright & Co.
HC Wainwright & Co.
Strong Buy
Reiterates
$12
Strong Buy Reiterates $12 +335.61% Mar 24, 2023
More Analyst Ratings

Financial Forecast

Revenue This Year
41.20M
from 61.64M
Decreased by -33.17%
Revenue Next Year
70.57M
from 41.20M
Increased by 71.31%
EPS This Year
-0.53
from -0.09
EPS Next Year
-0.71
from -0.53
Year 2019202020212022202320242025202620272028
Revenue
85.45M69.77M24.70M57.67M61.64M41.20M70.57M89.12M131.71M176.77M
Revenue Growth
-9.05%-18.35%-64.60%133.47%6.88%-33.17%71.31%26.28%47.79%34.21%
EPS
-0.31-0.81-0.66-0.73-0.09-0.53-0.71---
EPS Growth
----------
No. Analysts -----86444
Financial currency is EUR. Historical EPS numbers are GAAP, while forecasted numbers may be non-GAAP.

Revenue Forecast

Revenue 20242025202620272028
High 78.8M 193.2M 156.1M 172.1M 206.6M
Avg 41.2M 70.6M 89.1M 131.7M 176.8M
Low 10.8M 10.8M 21.2M 69.1M 140.4M

Revenue Growth

Revenue Growth 20242025202620272028
High
27.8%
369.0%
121.2%
93.1%
56.8%
Avg
-33.2%
71.3%
26.3%
47.8%
34.2%
Low
-82.5%
-73.8%
-70.0%
-22.4%
6.6%

EPS Forecast

EPS 20242025
High -0.32 -0.65
Avg -0.53 -0.71
Low -0.76 -0.76

EPS Growth

EPS Growth 20242025
High - -
Avg - -
Low - -
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.